What happened with the FDA and compounded GLP-1s, and who is still operating legally?

Short answer

• Starting in 2023 and continuing into 2024 the FDA stepped up enforcement against pharmacies and outsourcing facilities that were mass‑producing compounded versions of GLP‑1 drugs (semaglutide, tirzepatide, etc.). The agency has issued warning letters, asked firms to stop making and distributing products, worked with DOJ and state authorities on seizures/injunctions in some cases, and publicly warned consumers about safety and legal issues.
• That doesn’t mean all compounding stopped. What remains lawful: (A) FDA‑approved GLP‑1 medicines dispensed by licensed retail and specialty pharmacies, (B) 503A compounding pharmacies that make patient‑specific prescriptions in compliance with state board rules, and (C) FDA‑registered 503B outsourcing facilities that follow cGMP and aren’t making unlawful “copies” or distributing without prescriptions.

What the FDA was concerned about

• Many compounding businesses were offering off‑label “copies” of brand GLP‑1 products in large volumes (sometimes shipped across state lines) rather than making individualized preparations for a specific patient. The FDA treats those activities differently than legitimate compounding.
• Safety and quality concerns: sterility of injectable products, unverified ingredient sources, labeling, and lack of appropriate manufacturing controls.
• Legal issues: compounding an essentially identical version of an FDA‑approved drug (especially when made in commercial quantities) can violate the Federal Food, Drug, and Cosmetic Act and FDA exclusivity/intellectual‑property protections.

Who is still operating legally (what to expect)

• FDA‑approved brand products and generics (when available) dispensed by major pharmacies remain fully legal and are the safest option. Brand examples: Ozempic, Wegovy, Rybelsus (semaglutide — Novo Nordisk) and Mounjaro, Zepbound (tirzepatide — Eli Lilly).
• 503A compounding pharmacies: can legally compound for an individual patient based on a valid prescription. They’re regulated primarily by state boards of pharmacy and must follow state and professional standards.
• 503B outsourcing facilities: these are registered with FDA, inspectable by FDA, and must follow current Good Manufacturing Practices (cGMP). A 503B that is registered and compliant can legally produce certain compounded sterile products in larger quantities for healthcare facilities.
• Pharmacies or facilities that are on FDA warning‑letter lists or that have been subject to seizures/injunctions are not operating legally until they address the violations.

How to make sure a product or pharmacy is legal/safe

• Prefer FDA‑approved drugs when possible (Wegovy/Ozempic/Mounjaro/etc.) because they’re reviewed for safety, efficacy, and manufactured under cGMP.
• If you need a compounded product:
  • Ask whether the pharmacy is a 503A (state‑licensed) or a 503B (FDA‑registered) facility.
  • Ask for proof of sterility testing and a Certificate of Analysis (COA) for the active ingredient.
  • Check for PCAB accreditation (Pharmacy Compounding Accreditation Board) or other third‑party quality credentials and read state board inspection history.
  • Check the FDA website for any warning letters or enforcement actions against the pharmacy.
• Get your prescription from a licensed clinician (primary care, endocrinologist, or weight‑management specialist). Avoid purchasing injectables from unknown online vendors.

Practical recommendations (by name)

• Use FDA‑approved GLP‑1 prescriptions filled at major, licensed chains/specialty pharmacies (examples: CVS, Walgreens, Kroger/King Soopers pharmacies, Walmart, or your local independent pharmacy) — these dispense legal, approved products and have established quality controls.
• If you need compounding for a clinical reason, look for a PCAB‑accredited compounding pharmacy or an FDA‑registered 503B outsourcing facility (ask the pharmacy to identify which they are and give documentation).
• For clinical care and prescribing, consult your regular clinician or a reputable telehealth service with licensed prescribers; do not rely on companies offering unvetted compounded injectables shipped from unknown sources.

Where to check for up‑to‑date info

• FDA’s website: search for “compounding” and “GLP‑1” or look at FDA enforcement actions and warning letters.
• Your state board of pharmacy (for state licensing and inspection records).
• PCAB (for accredited compounding pharmacies).

If you want, I can:

• Search the FDA warning‑letter database (or show you how) for recent enforcement actions against specific compounding firms, or
• Help you evaluate a specific pharmacy (name it) to see if it’s operating legally and what accreditations/records to request.

Note: I’m not a lawyer. If you need binding legal advice about a pharmacy or business, consult an attorney with health‑care regulatory experience.